Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
88 studies found for:    "male pattern baldness" OR "Androgenetic Alopecia"
Show Display Options
Rank Status Study
21 Completed A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)
Condition: Androgenetic Alopecia
Interventions: Drug: SM04554;   Drug: Vehicle
22 Completed A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia
Condition: Androgenetic Alopecia
Interventions: Drug: CB-03-01 solution;   Drug: Minoxidil Solution 5%;   Drug: Placebo solution
23 Completed
Has Results
Treatment of Androgenetic Alopecia in Males
Conditions: Androgenetic Alopecia;   Hair Loss;   Male Pattern Baldness
Interventions: Device: HairMax LaserComb 2009, 7 Beam;   Device: HairMax LaserComb
24 Withdrawn The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia
Condition: Female Androgenetic Alopecia
Interventions: Drug: 5% Minoxidil;   Drug: 200mg Spironolactone;   Drug: 5mg Finasteride;   Other: Placebo
25 Completed Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia
Conditions: Androgenetic Alopecia;   Female Pattern Hair Loss
Intervention: Drug: minoxidil
26 Completed
Has Results
Treatment of Androgenic Alopecia in Males
Conditions: Androgenetic Alopecia;   Hair Loss;   Male Pattern Baldness
Interventions: Device: HairMax LaserComb;   Device: Control device
27 Completed
Has Results
Treatment of Androgenetic Alopecia in Females, 12 Beam
Conditions: Androgenetic Alopecia;   Hair Loss;   Female Pattern Baldness
Interventions: Device: HairMax LaserComb 2009 model 12 beam;   Device: Sham Device
28 Completed
Has Results
A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia
Conditions: Alopecia;   Androgenetic Alopecia
Intervention: Drug: Dutasteride 0.5mg oral tablets
29 Completed
Has Results
Treatment of Androgenetic Alopecia in Females, 9 Beam
Conditions: Androgenetic Alopecia;   Hair Loss;   Female Pattern Baldness
Interventions: Device: HairMax LaserComb;   Device: Control Device
30 Completed
Has Results
Clinical Trial in Females for Female Pattern Hair Loss
Condition: Androgenetic Alopecia
Interventions: Drug: 5% Minoxidil Topical Foam;   Drug: Vehicle Topical Foam
31 Unknown  Dose-Ranging Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss
Condition: Androgenetic Alopecia
Intervention: Drug: tetrapeptide aldehyde proteasome inhibitor (NEOSH101)
32 Completed Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss
Condition: Androgenetic Alopecia
Intervention: Drug: tetrapeptide aldehyde proteasome inhibitor (NEOSH101)
33 Completed Microarray Analysis of Scalp Biopsies After Minoxidil Treatment
Condition: Androgenetic Alopecia
Interventions: Drug: Minoxidil;   Other: Placebo
34 Active, not recruiting The Effect of Allogeneic Human Adipose Derived Stem Cell Component Extract on Androgenic Alopecia
Condition: Androgenic Alopecia
Intervention: Other: stem cell component extract
35 Completed Photosensitization Study in Androgenetic Alopecia
Condition: Androgenetic Alopecia
Interventions: Drug: Finasteride 0.25%;   Drug: Placebo for Finasteride 0.25%;   Drug: Negative Control
36 Completed Treatment of Androgenetic Alopecia in Males and Females
Condition: Androgenetic Alopecia
Interventions: Device: TopHat 655 rejuvenation system;   Device: Laser and/or Light Hair Rejuvenation System
37 Active, not recruiting Efficacy of Nutrition Supplement for Treatment of Men With Hair Loss
Condition: Androgenetic Alopecia
Interventions: Dietary Supplement: HCap Formula;   Dietary Supplement: Placebo
38 Active, not recruiting Adipose-derived SVF for Treatment of Alopecia
Condition: Androgenetic Alopecia
Intervention: Device: GID SVF-2
39 Completed A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss
Condition: Androgenetic Alopecia
Intervention: Drug: minoxidil
40 Completed Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111)
Condition: Androgenetic Alopecia
Interventions: Drug: MK0906, finasteride / Duration of Treatment : 48 Weeks;   Drug: Comparator : placebo (unspecified) / Duration of Treatment : 48 Weeks

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.